Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
1 drugs in development
By Therapeutic Area
top 1
R&D Momentum
46/100
Pipeline Velocity
15/100
Trial Completion Rate
100/100
Pipeline Concentration
50/100
Pipeline Freshness
67/100
Strategic Signals
Activity
Last 14 days
Benign Paroxysmal Positional Vertigo Recurrence After Canalith Re-positioning: A 12-Month Prospective Cohort Comparison of Vitamin D₃ Plus K₂, Vitamin D₃ Alone, and Maneuver Alone.
Examining the Impact of Phytoestrogens Supplementation on the Gene Expression and Premenstrual Syndrome in Perimenopausal Women Aged 40-55 in Jordan
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)